Germline variation of circadian pathway genes and prognosis of gastric cancer patients
Abstract
As we have summarised in this journal,1 germline DNA variation has been long recognised as a key component of the risk to develop to gastric carcinoma, the discovery pace being greatly accelerated by genome-wide association studies.2 More recently, growing evidence is accumulating also on the association between genetic variation and prognosis of patients with gastric cancer.3 4 Furthermore, investigators have demonstrated that alterations of the circadian rhythm can predispose to a variety of illnesses, including different types of malignancies and gastrointestinal diseases.5 6 Putting together these observations, we studied the relationship between circadian genes germline variation and the overall survival of 460 patients with TNM stage I to IV gastric carcinoma. We considered 21 single nucleotide polymorphisms (SNPs) of 14 circadian pathway genes. Genotyping was performed with real-time quantitative PCR using patient peripheral blood samples. Expression quantitative trait locus (eQTL) analysis was employed to …Keywords
This publication has 6 references indexed in Scilit:
- The Circadian Clock and Human HealthCurrent Biology, 2016
- Prognostic Significance of Tag SNP rs1045411 in HMGB1 of the Aggressive Gastric Cancer in a Chinese PopulationPLOS ONE, 2016
- Genetic polymorphisms in circadian negative feedback regulation genes predict overall survival and response to chemotherapy in gastric cancer patientsScientific Reports, 2016
- Genome-wide association study of gastric adenocarcinoma in Asia: a comparison of associations between cardia and non-cardia tumoursGut, 2015
- Genetic variation and gastric cancer risk: a field synopsis and meta-analysisGut, 2015
- The circadian clock: pacemaker and tumour suppressorNature Reviews Cancer, 2003